A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Texas residents who were exposed to greater levels of toxic metals were found to develop markers for type 2 diabetes earlier.

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

Recent research has found an association between moderate coffee and caffeine consumption and a lower risk of cardiometabolic ...

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

It's unclear whether the small increased risks of type 2 diabetes highlighted in this red-meat research hold any true ...

One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID ...